The possible $4bn cost to vaccine roll-out delay
The delay to the COVID-19 vaccine roll-out could cost the Government more than $4 billion and increase the likelihood of more lockdowns and restrictions.
The Government had initially set a roadmap to have 65% of people vaccinated by August, but this was now likely to be unachievable due to concerns about the AstraZeneca vaccine. Due to the risk of blood clots, it was recommended this specific jab was not given to those under-50, meaning Australia would have to wait for additional doses of the Pfizer jab which could take until Q4 2021 to arrive.
According to a report from the McKell Institute, in a best-case scenario, Australia would delay herd immunity by 116 days from the Government’s original estimate and cost $1.3 billion. However, in a worse scenario, it could be delayed by 353 days which would cost the Government $4.1 billion due to the increased risk of further lockdowns.
Executive director, Michael Buckland, said: “These delays will increase the chance of lockdown and the economic costs that come with them. It is vital that we are clear sighted about the cost and impact of Government’s action or inaction.
“Just as it was correct for the Government to measure the economic impact of state lockdowns, so too should the Government embrace the publication of clear information about the economic impact of its vaccination roll-out program.”
Recommended for you
The central bank has released its decision on the official cash rate following its November monetary policy meeting.
ASIC has cancelled the AFSL of a Melbourne-based managed investment scheme operator over a failure to pay industry levies and meet its statutory audit and financial reporting lodgement obligations.
Melbourne advice firm Hewison Private Wealth has marked four decades of service after making its start in 1985 as a “truly independent advice business” in a largely product-led market.
HLB Mann Judd Perth has announced its acquisition of a WA business advisory firm, growing its presence in the region, along with 10 appointments across the firm’s national network.

